Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.

Andrea Pretta,Pina Ziranu,Marco Puzzoni,E Lai,Giulia Orsi,N Liscia,Eleonora Molinaro,Stefano Mariani,Laura Riggi,Giulia Rovesti,Marco Dubois,Marco Migliari,Mara Persano,Giorgio Saba,V Impera,Francesca Musio,Erich Batzella,Laura Demurtas,Valeria Pusceddu,Giorgio Astara,Luca Faloppi,Andrea Casadei-Gardini,Kalliopi Andrikou,Stefano Cascinu,Mario Scartozzi

Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.

2020

Introduction:The association between pancreatic ductal adenocarcinoma (PDAC) and type 2 diabetes mellitus (DM2) has long been evaluated and the role of antidiabetic medications such as metformin ha...

Keywords:

Pancreatic cancer
Survival analysis
Insulin
Insulin treated type 2 diabetes mellitus
Type 2 Diabetes Mellitus
Metformin
Medicine
Gastroenterology
in patient
Internal medicine
pancreatic ductal adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations